Treatment of Angina Pectoris with a New Coronary Vasodilator, Isosorbide Dinitrate Sublingual (Isordil Subloral*)
- 1 September 1962
- journal article
- research article
- Published by SAGE Publications in Angiology
- Vol. 13 (9), 425-434
- https://doi.org/10.1177/000331976201300906
Abstract
Several articles are reviewed in which 515 patients with angina pectoris were treated with oral isosorbide dinitrate with good results in from 74 to 100% of the patients. The drug is also said to be of value sublingually. With the sublingual drug activity appears somewhat slower than with nitroglycerin. Its solubility is about the same as nitroglycerin but its period of activity is much longer, being approximately 4 hours. The only side-effect is headache, which varies from slight (about 20%) to moderate (about 20%), to throbbing one (about 10%). This headache can be relieved by salicylates or phenobarbital or by reducing the dosage. The results in 46 anginal patients treated was good.Keywords
This publication has 8 references indexed in Scilit:
- Comparative Responses to Various Nitrates in the Treatment of Angina PectorisPostgraduate Medicine, 1962
- The Clinical Pharmacology of Isosorbide Dinitrate: a Unique, New Nitrated PolyalcoholAngiology, 1961
- Isosorbide Dinitrate in Angina PectorisAngiology, 1961
- The Effects of Isosorbide Dinitrate On Coronary Vascular ResistanceAngiology, 1961
- Clinical Experiences With Isosorbide Dinitrate (Isordil)Angiology, 1961
- A Possible Application of Vasodilatators in Acute Coronary OcclusionAngiology, 1961
- Treatment With Isosorbide DinitrateAngiology, 1961
- CLINICAL ASPECTS FOR THE APPRAISAL OF DRUGS USED FOR THE TREATMENT OF THE ANGINAL SYNDROMEAnnals of the New York Academy of Sciences, 1956